Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study
about
Antiretroviral Drug Use in a Cohort of HIV-Uninfected Women in the United States: HIV Prevention Trials Network 064HIV acquisition among women from selected areas of the United States: a cohort studyImproved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter CohortVenue-based recruitment of women at elevated risk for HIV: an HIV Prevention Trials Network study.A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation.Antibody maturation and viral diversification in HIV-infected women.Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043).Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trialAssociation of pol diversity with antiretroviral treatment outcomes among HIV-infected African children.Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypesDecreasing Proportion of Recent Infections among Newly Diagnosed HIV-1 Cases in Switzerland, 2008 to 2013 Based on Line-Immunoassay-Based AlgorithmsHow can we better identify early HIV infections?Sexual Behaviors of US Women at Risk of HIV Acquisition: A Longitudinal Analysis of Findings from HPTN 064Antiretroviral pre-exposure prophylaxis implementation in the United States: a work in progressSocioecological factors influencing women's HIV risk in the United States: qualitative findings from the women's HIV SeroIncidence study (HPTN 064)Estimation of HIV incidence using multiple biomarkers.Cross-sectional HIV incidence estimation in HIV prevention research.Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting "Recent" HIV Infection and Calculating Population Incidence.HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithmRisk profile and HIV testing outcomes of women undergoing community-based testing in San Diego 2008-2014.Evaluation of the limiting antigen avidity EIA (LAg) in people who inject drugs in Greece.PrEP Implementation Science: State-of-the-Art and Research Agenda.Decision tree for accurate infection timing in individuals newly diagnosed with HIV-1 infection.Cross-country Association of Press Freedom and LGBT freedom with prevalence of persons living with HIV: implication for global strategy against HIV/AIDS.Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection.
P2860
Q28550081-9E6502C8-E3AB-4E93-8DC0-8DC7D71B6E0FQ33662739-D2098F54-0084-4FA0-87AB-D4D35368B9D0Q33706522-33D0AA5D-9EB8-4627-9E78-00B92458BCBBQ33714437-01FA8CD9-CCAC-4F8E-BE21-FE17ADB91529Q33812743-72C1FC8F-8CA1-4F8A-B0EE-1B73FC785F0CQ34608508-72B7D391-E4AF-4F40-B7D1-8949D84B7D44Q34848161-E843BB6E-FDFC-49F1-9EE9-86A3CAC5676EQ35043592-DF997593-66C4-4300-BCAD-53E27C203468Q35060472-3B8BB7C3-C6A9-4128-8F71-6E10E213E6F1Q35119643-AE2A7142-A7E2-4806-A72A-07C68BB9CC13Q35729544-128DCB4B-A7D5-4958-8343-51A8E1B3DD2CQ35814304-E85FD864-25CD-49FE-AD54-AF436F0E095EQ35862738-A59A9C35-B1F9-4580-A9EF-527C2A98FA7DQ35875714-4B74051C-7F38-42AA-AE60-D985EE758D51Q36105169-3E357E11-A630-4671-9FF6-1A2634382E5FQ36764936-2DCEABE6-1368-42A7-A75F-76F6C1C9FDBFQ37080530-68F4D553-D458-4CD2-AB30-B9E7B47B8D53Q37415771-D1842C64-E194-42A7-8E38-FAF615E89CB8Q37546766-1F11C82E-8926-40AF-A9B3-D8DE0C9EC1FBQ37625702-02E163D7-2AED-411F-9E61-68CB71F04398Q40485453-C2357827-7C5B-447E-8DB6-2578B9AEC490Q43241737-D5075794-176A-4570-8023-8D35A805F265Q47151503-965429F0-6C71-411C-8775-C7FAFF9221DAQ51152354-F33FE4A3-0873-4C88-8D05-A823C6DEAE36Q52681670-7480E95D-5422-4B6A-91DB-4066A067BDBB
P2860
Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Use of a multifaceted approach ...... ntion Trials Network 064 Study
@ast
Use of a multifaceted approach ...... ntion Trials Network 064 Study
@en
type
label
Use of a multifaceted approach ...... ntion Trials Network 064 Study
@ast
Use of a multifaceted approach ...... ntion Trials Network 064 Study
@en
prefLabel
Use of a multifaceted approach ...... ntion Trials Network 064 Study
@ast
Use of a multifaceted approach ...... ntion Trials Network 064 Study
@en
P2093
P2860
P50
P921
P356
P1476
Use of a multifaceted approach ...... ntion Trials Network 064 Study
@en
P2093
Ana S Vallari
Caroline E Mullis
James P Hughes
Jessica Justman
John Hackett
LeTanya Johnson-Lewis
Sally Hodder
P2860
P304
P356
10.1093/INFDIS/JIS658
P407
P577
2012-11-05T00:00:00Z